Pitfalls in pulmonary cytopathology

Diagnostic Cytopathology

Volumn 39, Issue 2, 2011, Pages 144-154

  Crapanzano, John P ^a   Saqi, Anjali ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

cytology; fine needle aspiration; lung; pulmonary

Indexed keywords

HORMONE RECEPTOR; KERATIN;

ADENOCARCINOMA; ARACTIVE SQUAMOUS ATYPIA; ASPIRATION BIOPSY; BASAL CELL CARCINOMA; BREAST CARCINOMA; BREAST METASTASIS; CARCINOID; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG HAMARTOMA; LUNG LESION; LUNG SQUAMOUS CELL CARCINOMA; LUNG TUMOR; NEUROENDOCRINE CARCINOMA; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

BIOPSY, FINE-NEEDLE; CYTODIAGNOSIS; CYTOLOGICAL TECHNIQUES; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LUNG; LUNG NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY SCANNERS, X-RAY COMPUTED;

EID: 79251479716     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21396     Document Type: Review

References (77)

1. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y,. The new World Health Organization classification of lung tumours. Eur Respir J 2001; 18: 1059-1068.
2. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA,. Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008; 83: 584-594.
3. Youlden DR, Cramb SM, Baade PD,. The International Epidemiology of Lung Cancer: Geographical distribution and secular trends. J Thorac Oncol 2008; 3: 819-831.
4. Edey AJ, Hansell DM,. Incidentally detected small pulmonary nodules on CT. Clin Radiol 2009; 64: 872-884.
5. Yuksel M, Akgul AG, Evman S, Batirel HF,. Suture and stapler granulomas: A word of caution. Eur J Cardiothorac Surg 2007; 31: 563-565.
6. Sica G, Vazquez MF, Altorki N, et al. PAX-5 expression in pulmonary neuroendocrine neoplasms: Its usefulness in surgical and fine-needle aspiration biopsy specimens. Am J Clin Pathol 2008; 129: 556-562.
7. Kim DJ, Kim KD, Shin DH, Ro JY, Chung KY,. Basaloid carcinoma of the lung: A really dismal histologic variant? Ann Thorac Surg 2003; 76: 1833-1837.
8. Brambilla E, Moro D, Veale D, et al. Basal cell (basaloid) carcinoma of the lung: A new morphologic and phenotypic entity with separate prognostic significance. Hum Pathol 1992; 23: 993-1003.
9. Halloush RA, Khasawneh FA, Saleh HA, Soubani AO, Piskorowski TJ, Al-Abbadi MA,. Fine needle aspiration cytology of lung lesions: A clinicopathological and cytopathological review of 150 cases with emphasis on the relation between the number of passes and the incidence of pneumothorax. Cytopathology 2007; 18: 44-51.
10. Thiessen R, Seely JM, Matzinger FR, et al. Necrotizing granuloma of the lung: Imaging characteristics and imaging-guided diagnosis. Am J Roentgenol 2007; 189: 1397-1401.
11. Scoggins WG SR, Frable WJ, O'Donahue WJ Jr,. False-positive cytologicial diagnosis of lung carcinoma in patients with pulmonary infarcts. Ann Thorac Surg 1977; 24: 474-480.
12. Afify A, Davila RM,. Pulmonary fine needle aspiration biopsy. Assessing the negative diagnosis. Acta Cytol 1999; 43: 601-604.
13. Zakowski MF, Gatscha RM, Zaman MB,. Negative predictive value of pulmonary fine needle aspiration cytology. Acta Cytol 1992; 36: 283-286.
14. Naryshkin S, Young NA,. Respiratory cytology: A review of non-neoplastic mimics of malignancy. Diagn Cytopathol 1993; 9: 89-97.
15. Crapanzano JP, Zakowski MF,. Diagnostic dilemmas in pulmonary cytology. Cancer 2001; 93: 364-375.
16. DeMay RM,. Respiratory cytology. In: The art and science of cytopathology. Chicago: ASCP Press; 1996; 952-953.
17. Ritter JH, Wick MR, Reyes A, Coffin CM, Dehner LP,. False-positive interpretations of carcinoma in exfoliative respiratory cytology. Report of two cases and a review of underlying disorders. Am J Clin Pathol 1995; 104: 133-140.
18. Grotte D, Stanley MW, Swanson PE, Henry-Stanley MJ, Davies S,. Reactive type II pneumocytes in bronchoalveolar lavage fluid from adult respiratory distress syndrome can be mistaken for cells of adenocarcinoma. Diagn Cytopathol 1990; 6: 317-322.
19. Stanley JH, Fish GD, Andriole JG, et al. Lung lesions: Cytologic diagnosis by fine-needle biopsy. Radiology 1987; 162: 389-391.
20. Di Costanzo F, Mazzoni F, Micol Mela M, et al. Bevacizumab in non-small cell lung cancer. Drugs 2008; 68: 737-746.
21. DeMay RM,. Statistics. In: The art and science of cytopathology. Chicago: ASCP Press; 1996; 948-950.
22. Thivolet-Bejui F,. Cytological pitfalls in bronchopulmonary tumors. Diagn Cytopathol 1997; 17: 412-416.
23. DeMay RM,. Lung. In: The art and science of cytopathology. Chicago: ASCP Press; 1996; 962.
24. Silverman JF,. Inflammatory and neoplastic processes of the lung: Differential diagnosis and pitfalls in FNA biopsies. Diagn Cytopathol 1995; 13: 448-462.
25. Silverman JF, Marrow HG,. Fine needle aspiration cytology of granulomatous diseases of the lung, including nontuberculous Mycobacterium infection. Acta Cytol 1985; 29: 535-541.
26. Manning JT Jr, Spjut HJ, Tschen JA,. Bronchioloalveolar carcinoma: The significance of two histopathologic types. Cancer 1984; 54: 525-534.
27. Fiorella RM, Gurley SD, Dubey S,. Cytologic distinction between bronchioalveolar carcinoma and reactive/reparative respiratory epithelium: A cytomorphometric analysis. Diagn Cytopathol 1998; 19: 270-273.
28. Silverman JF, Finley JL, Park HK, Strausbauch P, Unverferth M, Carney M,. Fine needle aspiration cytology of bronchioloalveolar-cell carcinoma of the lung. Acta Cytol 1985; 29: 887-894.
29. MacDonald LL, Yazdi HM,. Fine-needle aspiration biopsy of bronchioloalveolar carcinoma. Cancer 2001; 93: 29-34.
30. Johnston WW,. Type II pneumocytes in cytologic specimens. A diagnostic dilemma. Am J Clin Pathol 1992; 97: 608-609.
31. Stanley MW, Henry-Stanley MJ, Gajl-Peczalska KJ, Bitterman PB,. Hyperplasia of type II pneumocytes in acute lung injury. Cytologic findings of sequential bronchoalveolar lavage. Am J Clin Pathol 1992; 97: 669-677.
32. Policarpio-Nicolas ML, Wick MR,. False-positive interpretations in respiratory cytopathology: Exemplary cases and literature review. Diagn Cytopathol 2008; 36: 13-19.
33. Bewtra C, Dewan N, O'Donahue WJ Jr,. Exfoliative sputum cytology in pulmonary embolism. Acta Cytol 1983; 27: 489-496.
34. Kaminsky DA, Leiman G,. False-positive sputum cytology in a case of pulmonary infarction. Respir Care 2004; 49: 186-188.
35. Lawther RE, Graham AN, McCluggage WG, McGuigan JA,. Pulmonary infarct cytologically mimicking adenocarcinoma of the lung. Ann Thorac Surg 2002; 73: 1964-1965.
36. Naryshkin S, Bedrossian CW,. Selected mimics of malignancy in sputum and bronchoscopic cytology specimens. Diagn Cytopathol 1995; 13: 443-447.
37. Mourad WA, Vallieres E, Power RF, Hirji M,. Fine-needle aspiration cytology of bronchocentric granulomatosis: A potential diagnostic pitfall. Diagn Cytopathol 1996; 14: 263-267.
38. Saleh HA, Haapaniemi J, Khatib G, Sakr W,. Bronchioloalveolar carcinoma: Diagnostic pitfalls and immunocytochemical contribution. Diagn Cytopathol 1998; 18: 301-306.
39. Auger M, Katz RL, Johnston DA,. Differentiating cytological features of bronchioloalveolar carcinoma from adenocarcinoma of the lung in fine-needle aspirations: A statistical analysis of 27 cases. Diagn Cytopathol 1997; 16: 253-257.
40. Lozowski W, Hajdu SI,. Cytology and immunocytochemistry of bronchioloalveolar carcinoma. Acta Cytol 1987; 31: 717-725.
41. Zaman SS, van Hoeven KH, Slott S, Gupta PK,. Distinction between bronchioloalveolar carcinoma and hyperplastic pulmonary proliferations: A cytologic and morphometric analysis. Diagn Cytopathol 1997; 16: 396-401.
42. Stanley MW,. False-positive diagnoses in exfoliative cytology. Am J Clin Pathol 1995; 104: 117-119.
43. Wick MR, Matsubara O,. Pseudoneoplastic lesions of the lungs and pleural surfaces. In:, Leslie KO, editor. Practical pulmonary pathology. 1st ed. Philadelphia: Churchill Livingstone; 2005. p 650-652.
44. Koutras P, Urschel HC Jr, Paulson DL,. Hamartoma of the lung. J Thorac Cardiovasc Surg 1971; 61: 768-776.
45. van den Bosch JM, Wagenaar SS, Corrin B, Elbers JR, Knaepen PJ, Westermann CJ,. Mesenchymoma of the lung (so called hamartoma): A review of 154 parenchymal and endobronchial cases. Thorax 1987; 42: 790-793.
46. Ge F, Tong F, Li Z,. Diagnosis and treatment of pulmonary hamartoma. Chin Med Sci J 1998; 13: 61-62.
47. Silverman JF,. Fine needle aspiration cytology of the thorax and abdomen. New York: Churchill Livingstone; 1996.
48. Wood B, Swarbrick N, Frost F,. Diagnosis of pulmonary hamartoma by fine needle biopsy. Acta Cytol 2008; 52: 412-417.
49. Hughes JH, Young NA, Wilbur DC, Renshaw AA, Mody DR,. Fine-needle aspiration of pulmonary hamartoma: A common source of false-positive diagnoses in the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology. Arch Pathol Lab Med 2005; 129: 19-22.
50. Saqi A, Shaham D, Scognamiglio T, et al. Incidence and cytological features of pulmonary hamartomas indeterminate on CT scan. Cytopathology 2007; 19: 185-191.
51. Incze JS, Lui PS,. Morphology of the epithelial component of human lung hamartomas. Hum Pathol 1977; 8: 411-419.
52. Moro D, Brichon PY, Brambilla E, Veale D, Labat F, Brambilla C,. Basaloid bronchial carcinoma. A histologic group with a poor prognosis. Cancer 1994; 73: 2734-2739.
53. Nagakawa H, Hiroshima K, Takiguchi Y, et al. Basaloid squamous-cell carcinoma of the lung in a young woman. Int J Clin Oncol 2006; 11: 66-68.
54. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC,. World health organization classification of tumors. In:, Kleihues P, Sobin LH, editors. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004. 344 p.
55. Crapanzano JP, Loukeris K, Borczuk AC, Saqi A,. Cytological, histological, and immunohistochemical findings of pulmonary carcinomas with basaloid features. Diagn Cytopathol, in press.
56. Vesoulis Z,. Metastatic laryngeal basaloid squamous cell carcinoma simulating primary small cell carcinoma of the lung on fine needle aspiration lung biopsy. A case report. Acta Cytol 1998; 42: 783-787.
57. Kargi A, Gurel D, Tuna B,. The diagnostic value of TTF-1, CK 5/6, and p63 immunostaining in classification of lung carcinomas. Appl Immunohistochem Mol Morphol 2007; 15: 415-420.
58. Dahlstrom JE, Langdale-Smith GM, James DT,. Fine needle aspiration cytology of pulmonary lesions: A reliable diagnostic test. Pathology 2001; 33: 13-16.
59. Lovett JV, Manalo PB, Barcia TC, Bomberger RA, McGregor DB,. Diagnosis of pulmonary masses by fine-needle aspiration. Am J Surg 1988; 156: 441-445.
60. Mitchell ML, King DE, Bonfiglio TA, Patten SF Jr,. Pulmonary fine needle aspiration cytopathology. A five-year correlation study. Acta Cytol 1984; 28: 72-76.
61. Chhieng DC, Cangiarella JF, Zakowski MF, Goswami S, Cohen JM, Yee HT,. Use of thyroid transcription factor 1. PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Cancer 2001; 93: 330-336.
62. Dabbs DJ, Landreneau RJ, Liu Y, et al. Detection of estrogen receptor by immunohistochemistry in pulmonary adenocarcinoma. Ann Thorac Surg 2002; 73: 403-405; discussion 406.
63. Canver CC, Memoli VA, Vanderveer PL, Dingivan CA, Mentzer RM, Jr,. Sex hormone receptors in non-small-cell lung cancer in human beings. J Thorac Cardiovasc Surg 1994; 108: 153-157.
64. Kaiser U, Hofmann J, Schilli M, et al. Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer. Int J Cancer 1996; 67: 357-364.
65. Kaufmann O, Kother S, Dietel M,. Use of antibodies against estrogen and progesterone receptors to identify metastatic breast and ovarian carcinomas by conventional immunohistochemical and tyramide signal amplification methods. Mod Pathol 1998; 11: 357-363.
66. Sica G, Wagner PL, Altorki N, et al. Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors. Arch Pathol Lab Med 2008; 132: 1889-1895.
67. Su JM, Hsu HK, Chang H, et al. Expression of estrogen and progesterone receptors in non-small-cell lung cancer: Immunohistochemical study. Anticancer Res 1996; 16: 3803-3806.
68. Makretsov N, Gilks CB, Coldman AJ, Hayes M, Huntsman D,. Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer. Hum Pathol 2003; 34: 1001-1008.
69. Saqi A, Oster MW, Vazquez MF,. Metastatic mammary carcinomas with endocrine features: Potential diagnostic pitfalls. Diagn Cytopathol 2005; 33: 49-53.
70. Renshaw AA, Voytek TM, Haja J, Wilbur DC,. Distinguishing small cell carcinoma from non-small cell carcinoma of the lung: Correlating cytologic features and performance in the College of American Pathologists Non-Gynecologic Cytology Program. Arch Pathol Lab Med 2005; 129: 619-623. (Pubitemid 40616964)
71. Thatcher N, Chang A, Parikh P, et al. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: Results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer). Lancet 2005; 366: 1527-1537.
72. Perez-Soler R, Chachoua A, Hammond LA, et al. Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer. J Clin Oncol 2004; 22: 3238-3247.
73. Hanna N, Shepherd FA, Fossella FV, et al. Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol 2004; 22: 1589-1597.
74. Sandler A, Gray R, Perry MC, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006; 355: 2542-2550.
75. Vazquez MF, Koizumi JH, Henschke CI, Yankelevitz DF,. Reliability of cytologic diagnosis of early lung cancer. Cancer 2007; 111: 252-258.
76. Loukeris K, Saqi A, Crapanzano JP, Vazquez MF,. Cell-block material as a predictor of squamous subtype of non-small cell lung carcinoma. Cancer Cytopathol 2008; 114: 412-413.
77. Loukeris K, Crapanzano JP, Vazquez MF, Saqi A,. Cell-block material as a predictor of adenocarcinoma subtype. Cancer Cytopathol 2008; 114: 411-412.